ICVTS Click here to go to Siemens website
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Arun K. Srinivasan
Michael J. Shackcloth
Antony D. Grayson
Brian M. Fabri
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Srinivasan, A. K.
Right arrow Articles by Fabri, B. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Srinivasan, A. K.
Right arrow Articles by Fabri, B. M.
Related Collections
Right arrow Cardiac - pharmacology
Right arrow Coronary disease
Interactive Cardiovascular and Thoracic Surgery 2:495-500(2003)
© 2003 European Association of Cardio-Thoracic Surgery


Work in progress report - Coronary

Preoperative ß-blocker therapy in coronary artery bypass surgery: a propensity score analysis of outcomes

Arun K. Srinivasana, Michael J. Shackclotha, Antony D. Graysonb and Brian M. Fabria,*

a Department of Cardiothoracic Surgery, The Cardiothoracic Centre-Liverpool, Thomas Drive, Liverpool L14 3PE, UK
b Department of Clinical Governance, The Cardiothoracic Centre-Liverpool, Thomas Drive, Liverpool L14 3PE, UK

* Corresponding author. Tel.: +44-151-293-2397; fax: +44-151-220-8573
brian.fabri{at}ctc.nhs.uk

Preoperative ß-blockade in patients undergoing coronary artery bypass grafting (CABG) has recently been shown to be beneficial in improving the early outcomes after surgery. We aimed to quantify the effect of preoperative ß-blockade on outcomes in our own patient population. We performed a retrospective analysis on CABG patients identified from our prospectively collected cardiac surgery database. Logistic regression was used to adjust in-hospital outcomes for differences in patient and disease characteristics. Treatment selection bias was controlled by deriving a propensity score for ß-blocker therapy. Consecutive patients (4381) underwent CABG on cardiopulmonary bypass between 1 April 1997 and 31 March 2002, with 2836 (64.7%) on preoperative ß-blocker therapy. After adjustment with the propensity score, ß-blocker therapy was significantly associated with a reduction in post-operative stroke (adjusted OR 0.59, ). The incidence of atrial arrhythmia was significantly increased in patients who had received preoperative ß-blockers (adjusted OR 1.21, ). There were no significant differences in operative mortality or other morbidity outcomes. Preoperative ß-blocker therapy significantly reduces the incidence of post-operative cerebrovascular events in patients undergoing on-pump coronary artery bypass surgery.

Key Words: ß-Blockers; Coronary artery bypass grafting; Stroke; Propensity score







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2003 European Association for Cardio-thoracic Surgery